Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Bicalutamide shows promise for treating female hair loss.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Finasteride increases CD8+ T cells in BPH tissues.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.